New depression pill shows promise in Head-to-Head trial
NCT ID NCT07253207
First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 17 times
Summary
This study tested a new extended-release drug, levomilnacipran, for adults with major depression. 392 participants took either the new drug or an existing one (duloxetine) for 8 weeks. The goal was to see if the new drug works as well or better at reducing depression symptoms, measured by a standard depression scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Affiliated Brain Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510370, China
-
Beijing Anding Hospital Capital Medical University
Beijing, Beijing Municipality, 100000, China
-
Beijing HuiLongGuan Hospital
Beijing, Beijing Municipality, 102200, China
-
Chengdu Fourth People's Hospital
Chengdu, Sichuan, 610041, China
-
Chongqing Mental Health Center
Chongqing, Chongqing Municipality, 401147, China
-
Hangzhou Seventh People's Hospital
Hangzhou, Zhejiang, 310007, China
-
Hebei Provincial Mental Health Center
Baoding, Hebei, 071030, China
-
Hefei Fourth People's Hospital
Hefei, Anhui, 230031, China
-
Hunan Provincial Second People's Hospital
Changsha, Hunan, 410007, China
-
Huzhou Third People's Hospital
Huzhou, Zhejiang, 313000, China
-
Jiangxi Provincial Psychiatric Hospital
Nanchang, Jiangxi, 330029, China
-
Jilin Provincial Neuropsychiatric Hospital
Siping, Jilin, 136000, China
-
Linfen Central Hospital
Linfen, Shanxi, 041099, China
-
Nantong Mental Health Center
Nantong, Jiangsu, 226005, China
-
Ningbo University Affiliated Kangning Hospital
Ningbo, Zhejiang, 315201, China
-
Shandong Provincial Mental Health Center
Jinan, Shandong, 250014, China
-
Shanghai Pudong New Area Mental Health Center
Shanghai, Shanghai Municipality, 200124, China
-
Suzhou Guangji Hospital
Suzhou, Jiangsu, 215131, China
-
The First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, 650032, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330006, China
-
The First Affiliated Hospital of Xi 'an Jiaotong University
Xi'an, Shaanxi, 710061, China
-
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
-
The First Hospital of Shanxi Medical University
Taiyuan, Shanxi, 030001, China
-
Tianjin Fourth Central Hospital
Tianjin, Tianjin Municipality, 300074, China
-
Wuhu Hospital of Beijing Anding Hospital, Capital Medical University
Wuhu, Anhui, 241003, China
-
Wuxi Mental Health Center
Wuxi, Jiangsu, 214000, China
-
Xi 'an Mental Health Center
Xi'an, Shaanxi, 710199, China
-
Zhenjiang Mental Health Center
Zhenjiang, Jiangsu, 212021, China
Conditions
Explore the condition pages connected to this study.